Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates
1. Nuzolvence (zoliflodacin) is the first single‑dose oral agent for uncomplicated urogenital gonorrhea, showing non‑inferior cure rates to ceftriaxone‑based therapy...